Log in to save to my catalogue

Comparison of Adverse Effects of Two SARS-CoV-2 Vaccines Administered in Workers of the University o...

Comparison of Adverse Effects of Two SARS-CoV-2 Vaccines Administered in Workers of the University o...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1fdd6d1625d84b3f9d05c2f137cca760

Comparison of Adverse Effects of Two SARS-CoV-2 Vaccines Administered in Workers of the University of Padova

About this item

Full title

Comparison of Adverse Effects of Two SARS-CoV-2 Vaccines Administered in Workers of the University of Padova

Publisher

Switzerland: MDPI AG

Journal title

Vaccines (Basel), 2023-05, Vol.11 (5), p.951

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Introduction: In Italy, on December 2020, workers in the education sector were identified as a priority population to be vaccinated against COVID-19. The first authorised vaccines were the Pfizer-BioNTech mRNA (BNT162b2) and the Oxford-AstraZeneca adenovirus vectored (ChAdOx1 nCoV-19) vaccines. Aim: To investigate the adverse effects of two SARS-Co...

Alternative Titles

Full title

Comparison of Adverse Effects of Two SARS-CoV-2 Vaccines Administered in Workers of the University of Padova

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1fdd6d1625d84b3f9d05c2f137cca760

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1fdd6d1625d84b3f9d05c2f137cca760

Other Identifiers

ISSN

2076-393X

E-ISSN

2076-393X

DOI

10.3390/vaccines11050951

How to access this item